Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model

We previously reported that withaferin A (WA), a natural compound, deters prostate cancer by inhibiting AKT while inducing apoptosis. In the current study, we examined its chemopreventive efficacy against carcinogenesis in the prostate using the transgenic adenocarcinoma of mouse prostate (TRAMP) mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Suman, Suman, Das, Trinath P., Moselhy, Jim, Pal, Deeksha, Kolluru, Venkatesh, Alatassi, Houda, Ankem, Murali K., Damodaran, Chendil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288218/
https://www.ncbi.nlm.nih.gov/pubmed/27447565
http://dx.doi.org/10.18632/oncotarget.10733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288218/
https://www.ncbi.nlm.nih.gov/pubmed/27447565
http://dx.doi.org/10.18632/oncotarget.10733

Ejemplares similares